FDA grants EUA for Visby Medical's COVID-19 test

Updated Sep 13, 2021
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400

The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for Visby Medical's COVID-19 reverse transcription polymerase chain reaction test for pooled samples.

The authorization expands the company's first EUA for single-patient-sample testing to pooled testing of up to five samples at once for SARS-CoV-2, Visby said.

Page 1 of 33
Next Page